Transforming the genome to drug discovery

被引：14

作者：

Murcko, M ^{[1
]}

Caron, P ^{[1
]}

机构：

[1] Vertex Pharmaceut, Cambridge, MA 02139 USA

来源：

DRUG DISCOVERY TODAY | 2002年 / 7卷 / 11期

关键词：

D O I：

10.1016/S1359-6446(02)02267-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：583 / 584

页数：2

共 9 条

[1] Chemogenomic approaches to drug discovery - Commentary [J].

Caron, PR ;

Mullican, MD ;

Mashal, RD ;

Wilson, KP ;

Su, MS ;

Murcko, MA .

CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (04) :464-470

[2] The role of innovation in drug development [J].

Drews, J ;

Ryser, S .

NATURE BIOTECHNOLOGY, 1997, 15 (13) :1318-1319

[3] A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase [J].

Fox, T ;

Coll, JT ;

Xie, XL ;

Ford, PJ ;

Germann, UA ;

Porter, MD ;

Pazhanisamy, S ;

Fleming, MA ;

Galullo, V ;

Su, MSS ;

Wilson, KP .

PROTEIN SCIENCE, 1998, 7 (11) :2249-2255

[4] Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic era [J].

Frye, SV .

CHEMISTRY & BIOLOGY, 1999, 6 (01) :R3-R7

[5] Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket [J].

Gum, RJ ;

McLaughlin, MM ;

Kumar, S ;

Wang, ZL ;

Bower, MJ ;

Lee, JC ;

Adams, JL ;

Livi, GP ;

Goldsmith, EJ ;

Young, PR .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (25) :15605-15610

[6] Genomics: Journey to the center of biology [J].

Lander, ES ;

Weinberg, RA .

SCIENCE, 2000, 287 (5459) :1777-1782

[7] Molecular basis for p38 protein kinase inhibitor specificity [J].

Lisnock, JM ;

Tebben, A ;

Frantz, B ;

O'Neill, EA ;

Croft, G ;

O'Keefe, SJ ;

Li, B ;

Hacker, C ;

de Laszlo, S ;

Smith, A ;

Libby, B ;

Liverton, N ;

Hermes, J ;

LoGrasso, P .

BIOCHEMISTRY, 1998, 37 (47) :16573-16581

[8] Forecasting roles of combinatorial chemistry in the age of genomically derived drug discovery targets [J].

Thorpe, DS .

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2000, 3 (05) :421-436

[9] The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase [J].

Wilson, KP ;

McCaffrey, PG ;

Hsiao, K ;

Pazhanisamy, S ;

Galullo, V ;

Bemis, GW ;

Fitzgibbon, MJ ;

Garon, PR ;

Murcko, MA ;

Su, MSS .

CHEMISTRY & BIOLOGY, 1997, 4 (06) :423-431

← 1 →